These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. Cutolo M, Foppiani L, Minuto F. J Endocrinol Invest; 2002 Oct 01; 25(10 Suppl):19-23. PubMed ID: 12508908 [Abstract] [Full Text] [Related]
6. [Coexistence of polymyalgia rheumatica/temporal arteritis and chronic polyarthritis]. Brückle W, Schattenkirchner M. Z Rheumatol; 1989 Oct 01; 48(1):1-5. PubMed ID: 2652936 [Abstract] [Full Text] [Related]
7. Predictors of glucocorticoid-free remission in patients with polymyalgia rheumatica treated with prednisolone. Hattori K, Hirano Y, Kojima T. Int J Rheum Dis; 2020 Nov 01; 23(11):1581-1586. PubMed ID: 32996694 [Abstract] [Full Text] [Related]
8. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database. Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A. Rheumatol Int; 2018 Apr 01; 38(4):569-577. PubMed ID: 29124397 [Abstract] [Full Text] [Related]
9. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. JAMA; 2016 Jun 14; 315(22):2442-58. PubMed ID: 27299619 [Abstract] [Full Text] [Related]
10. Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis. Borresen SW, Klose M, Baslund B, Rasmussen ÅK, Hilsted L, Friis-Hansen L, Locht H, Hansen A, Hetland ML, Lydolph MC, Feldt-Rasmussen U. Eur J Endocrinol; 2017 Oct 14; 177(4):287-295. PubMed ID: 28877961 [Abstract] [Full Text] [Related]
13. Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides-Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort. Palmowski A, Wiebe E, Muche B, Hermann S, Dejaco C, Matteson EL, Buttgereit F. Cells; 2022 Feb 04; 11(3):. PubMed ID: 35159345 [Abstract] [Full Text] [Related]
14. Thin-section chest CT findings in polymyalgia rheumatica: a comparison between with and without rheumatoid arthritis. Kinoshita S, Aoki T, Takahashi H, Oki H, Hayashida Y, Saito K, Tanaka Y, Korogi Y. Clin Imaging; 2016 Feb 04; 40(3):382-5. PubMed ID: 27133672 [Abstract] [Full Text] [Related]
16. [Clinical features in patients with polymyalgia rheumatica]. Aoki Y, Iwamoto M, Minota S. Nihon Rinsho Meneki Gakkai Kaishi; 2009 Aug 04; 32(4):274-8. PubMed ID: 19721349 [Abstract] [Full Text] [Related]
17. Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica. Camellino D, Matteson EL, Buttgereit F, Dejaco C. Nat Rev Rheumatol; 2020 Sep 04; 16(9):481-495. PubMed ID: 32759996 [Abstract] [Full Text] [Related]
18. Coexistence of temporal arteritis/polymyalgia rheumatica and rheumatoid arthritis. Omdal R, Husby G. Clin Rheumatol; 1984 Dec 04; 3(4):525-7. PubMed ID: 6525788 [Abstract] [Full Text] [Related]
19. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica. van der Geest KS, Abdulahad WH, Chalan P, Rutgers A, Horst G, Huitema MG, Roffel MP, Roozendaal C, Kluin PM, Bos NA, Boots AM, Brouwer E. Arthritis Rheumatol; 2014 Jul 04; 66(7):1927-38. PubMed ID: 24623536 [Abstract] [Full Text] [Related]